Treatment of High-Risk Neuroblastoma by Julie Krystal, Jennifer H. Foster

Get full text

Neuroblastoma in the Era of Precision Medicine: A Clinical Review by Andrew Wahba, Russ Wolters, Jennifer H. Foster

Get full text

The Anti-Tumor Activity of the NEDD8 Inhibitor Pevonedistat in Neuroblastoma by Jennifer H. Foster, Eveline Barbieri, Linna Zhang, Kathleen A. Scorsone, Myrthala Moreno-Smith, Peter Zage, Terzah M. Horton

Get full text

Case report: Spindle cell neoplasm presenting as a spontaneous intestinal perforation in a term infant by Lauren T. Callaghan, Anthea Lafreniere, Anthea Lafreniere, Ekene A. Onwuka, Ekene A. Onwuka, Ross M. Beckman, Ross M. Beckman, Jennifer H. Foster, Jennifer H. Foster, Norma Quintanilla, Norma Quintanilla, Charleta Guillory, Charleta Guillory, Timothy C. Lee, Timothy C. Lee, Lily S. Cheng, Lily S. Cheng

Get full text

Targeting MDM2 for Neuroblastoma Therapy: In Vitro and In Vivo Anticancer Activity and Mechanism of Action by Wei Wang, Xinjie Wang, Mehrdad Rajaei, Ji Youn Youn, Atif Zafar, Hemantkumar Deokar, John K. Buolamwini, Jianhua Yang, Jennifer H. Foster, Jia Zhou, Ruiwen Zhang

Get full text

ERK Inhibitor Ulixertinib Inhibits High-Risk Neuroblastoma Growth In Vitro and In Vivo by Yang Yu, Yanling Zhao, Jongmin Choi, Zhongcheng Shi, Linjie Guo, John Elizarraras, Andy Gu, Feng Cheng, Yanxin Pei, Dai Lu, Muller Fabbri, Saurabh Agarwal, Chunchao Zhang, Sung Yun Jung, Jennifer H. Foster, Jianhua Yang

Get full text

MYCN-driven fatty acid uptake is a metabolic vulnerability in neuroblastoma by Ling Tao, Mahmoud A. Mohammad, Giorgio Milazzo, Myrthala Moreno-Smith, Tajhal D. Patel, Barry Zorman, Andrew Badachhape, Blanca E. Hernandez, Amber B. Wolf, Zihua Zeng, Jennifer H. Foster, Sara Aloisi, Pavel Sumazin, Youli Zu, John Hicks, Ketan B. Ghaghada, Nagireddy Putluri, Giovanni Perini, Cristian Coarfa, Eveline Barbieri

Get full text